Restylane

Restylane Indications/Uses

Manufacturer:

Galderma

Distributor:

Forewide
/
DCH Auriga - Healthcare
Full Prescribing Info
Indications/Uses
Before the first treatment session, it is recommended to contact the local Galderma representative or Restylane distributor for more information about injection techniques and training opportunities. This product is only intended to be administered by authorized personnel in accordance with local legislation.
Restylane: This product is intended to be used for facial tissue augmentation. It is recommended to be used for the correction of wrinkles and for lip enhancement. It should be injected into the middle part of the dermis layer or in the submucosal layer of the lip. For facial areas with limited soft tissue support and soft tissue cover, e.g. the periorbital region, injection into the subcutaneous fatty tissue or supraperiostal administration are recommended.
Restylane Defyne: The product is intended to augment the volume of facial tissues. It is recommended to be used for correction of severe wrinkles, or to redefine the shape of the lips, cheeks or tear troughs. Depending on the area to be treated and the tissue support, the product should be injected in the mid to deep dermis, submucosal layer of the lips, subcutis or supraperiostic zone. Lidocaine is added to the formulation to diminish the pain resulting from the injection during the treatment.
Restylane Kysse: The product is intended to restore or augment the volume of the lips. It should be injected into the submucosal layer of the lip. Lidocaine is added to the formulation to diminish the pain resulting from the injection during the treatment.
Restylane Lyft: This product is intended to be used for facial tissue augmentation. It is recommended to be used for shaping the contours of the face, the correction of folds and for lip enhancement. It should be injected into the deep layer of the dermis and/or the surface layer of the subcutis or in the submucosal layer of the lip. For facial areas with limited soft tissue support and soft tissue cover, e.g. the periorbital region, injection into the subcutaneous fatty tissue or supraperiostal administration are recommended.
Restylane Lyps Lidocaine: This product is intended for lip enhancement. It should be administered by submucosal injection. The addition of lidocaine provides a pain relieving effect during treatment.
Restylane Refyne: The product is intended to augment the volume of facial tissues. It is recommended to be used for correction of moderate wrinkles, or to redefine the shape of the lips, cheeks or tear troughs. Depending on the area to be treated and the tissue support, the product should be injected in the mid to deep dermis, submucosal layer of the lips, subcutis or supraperiostic zone. Lidocaine is added to the formulation to diminish the pain resulting from the injection during the treatment.
Restylane Volyme: The product is intended to augment the volume of facial tissues. It is recommended to be used for the correction of facial volume, for instance cheeks and chin. Depending on the area to be treated and the tissue support, the product should be injected into the supraperiostic zone or subcutis. Lidocaine is added to the formulation to diminish the pain resulting from the injection during the treatment.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in